Related Experiment Video
Updated: Jul 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Inhibition of Hepatitis B virus cccDNA replication by siRNA
Gui-Qiu Li1, Hong-Xi Gu, Di Li
1Department of Microbiology, Harbin Medical University, Harbin, Heilongjiang Province, China.
Abstract:
The development of an effective therapy for Hepatitis B virus (HBV) infection is still a challenge. Progress in RNA interference (RNAi) has shed slight on developing a new anti-HBV strategy. Here, we present a series of experiments showing a significant reduction in HBV transcripts and replication intermediates in HepG2.2.15cells by vector-based siRNA targeted nuclear localization signal (NLS) region. More importantly, we showed that siRNA1 markedly inhibited HBV covalently closed circular DNA (cccDNA) replication. Our results indicated that HBV NLS may serve as a novel RNAi target to combat HBV infection, which can enhance anti-HBV efficacy and overcome the drawbacks of current therapies.
Related Concept Videos
Hepatitis
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

